Relmada Therapeutics (RLMD) Q3 2023 Earnings Report

446 Followers

RLMD Upcoming Earnings

Relmada Therapeutics's next earnings date is estimated for March 23, 2027, based on past reporting schedules.

Q3 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

RLMD earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Mar 23, 2027	2026 (Q4)	-0.13-	-0.27	―	―
Nov 12, 2026	2026 (Q3)	-0.14-0.12	-0.3	60.00% (+0.18)
Aug 06, 2026	2026 (Q2)	-0.20-0.11	-0.3	63.33% (+0.19)
May 12, 2026	2026 (Q1)	-0.20-0.22	-0.58	62.07% (+0.36)
Mar 19, 2026	2025 (Q4)	-0.15-0.27	-0.62	56.45% (+0.35)
Nov 13, 2025	2025 (Q3)	-0.42-0.30	-0.72	58.33% (+0.42)
Aug 07, 2025	2025 (Q2)	-0.46-0.30	-0.59	49.15% (+0.29)
May 12, 2025	2025 (Q1)	-0.48-0.58	-0.72	19.44% (+0.14)
Mar 27, 2025	2024 (Q4)	-0.67-0.62	-0.84	26.19% (+0.22)
Nov 07, 2024	2024 (Q3)	-0.68-0.72	-0.73	1.37% (+0.01)
Aug 07, 2024	2024 (Q2)	-0.83-0.59	-0.84	29.76% (+0.25)
May 08, 2024	2024 (Q1)	-0.85-0.72	-0.87	17.24% (+0.15)
Mar 19, 2024	2023 (Q4)	-0.83-0.84	-1.28	34.38% (+0.44)
Nov 08, 2023	2023 (Q3)	-0.91-0.73	-1.31	44.27% (+0.58)
Aug 08, 2023	2023 (Q2)	-0.90-0.84	-1.33	36.84% (+0.49)
May 11, 2023	2023 (Q1)	-0.89-0.87	-1.4	37.86% (+0.53)
Mar 23, 2023	2022 (Q4)	-1.33-1.28	-1.8	28.89% (+0.52)
Nov 10, 2022	2022 (Q3)	-1.45-1.31	-2.44	46.31% (+1.13)
Aug 11, 2022	2022 (Q2)	-1.27-1.33	-1.56	14.74% (+0.23)
May 05, 2022	2022 (Q1)	-1.27-1.40	-1.34	-4.48% (-0.06)
Mar 23, 2022	2021 (Q4)	-1.83-1.80	-1.28	-40.63% (-0.52)
Nov 11, 2021	2021 (Q3)	-1.60-2.44	-1.05	-132.38% (-1.39)
Aug 10, 2021	2021 (Q2)	-1.47-1.56	-0.73	-113.70% (-0.83)
May 12, 2021	2021 (Q1)	―-1.34	-0.72	-86.11% (-0.62)
Mar 23, 2021	2020 (Q4)	―-1.28	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed